BCDA - BioCardia, Inc.

QQQ $ 479.30 $ 2.47 (0.52 %)

DIA $ 386.46 $ -0.42 (-0.11 %)

SPY $ 542.65 $ 0.33 (0.06 %)

TLT $ 94.67 $ 0.79 (0.84 %)

GLD $ 215.76 $ 2.76 (1.3 %)

Previous Close

$ 3.41

Open

$ 3.41

Bid

$ 0.00 x 0

Ask

$ 3.51 x 100

Day's Range

$ 3.41 - $ 3.55

52 Week Range

$ 3.20 - $ 43.80

Volume

56,625

Average Volume

Market Cap

6.21M

Beta (5Y Monthly)

$ 0.29

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-27-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	03-29-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-10-2022	06-30-2022	10-Q
9	05-11-2022	03-31-2022	10-Q
10	03-29-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-30-2021	12-31-2020	10-K
15	11-10-2020	09-30-2020	10-Q
16	08-13-2020	06-30-2020	10-Q
17	05-15-2020	03-31-2020	10-Q
18	04-09-2020	12-31-2019	10-K
19	11-19-2019	09-30-2019	10-Q
20	08-14-2019	06-30-2019	10-Q
21	05-15-2019	03-31-2019	10-Q
22	04-02-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-16-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-14-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-30-2017	12-31-2016	10-K
31	10-17-2016	09-30-2016	10-Q
32	08-02-2016	06-30-2016	10-Q
33	05-03-2016	03-31-2016	10-Q
34	03-25-2016	12-31-2015	10-K
35	10-29-2015	09-30-2015	10-Q
36	08-12-2015	06-30-2015	10-Q
37	05-12-2015	03-31-2015	10-Q
38	03-24-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	08-06-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-skye-bioscience-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Skye Bioscience Shares Are Trading Low...
06/10/2024 18:10:40

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
06/10/2024 12:06:22

why-kkr-shares-are-trading-higher-by-10-here-are-20-stocks-moving-premarket

Why KKR Shares Are Trading Higher By 10%; ...
06/10/2024 09:59:44

What's Going with BioCardia Stock Friday?
06/07/2024 14:35:43

On Friday before the market open, BioCardia announced it received approval from the United States Patent Office for its applic...

BioCardia Shares Resume Trade
06/07/2024 13:46:23

BioCardia Shares Halted On Circuit Breaker...
06/07/2024 13:43:00

Market-Moving News for June 7th
06/07/2024 12:26:31

GME: -16% | GameStop shares are trading lower after the company released worse-than-expected Q1 results before schedule and fil...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
06/07/2024 12:08:00

BioCardia Says US Patent Office Has Grante...
06/07/2024 11:01:36

Radial artery delivery is a means by which cardiac catheters are advanced through a blood vessel in a patient's wrist to tr...

BioCardia Shares Resume Trade
05/30/2024 13:00:59

Trading Halt: Halt status updated at 8:55:...
05/30/2024 12:55:04

Trading Halt: Halted at 7:50:00 p.m. ET - ...
05/29/2024 23:50:04

HC Wainwright & Co. Reiterates Buy on BioC...
05/29/2024 17:29:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $4 price target.

BioCardia Intends To Effect Reverse Stock ...
05/21/2024 21:02:59

The reverse stock split will become effective at 12:01 a.m. Eastern Daylight Time on Thursday, May 30, 2024.

BioCardia Q1 EPS $(0.09) Up From $(0.17) Y...
05/14/2024 20:07:45

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.09) per share. This is a 47.06 percent increase over losses of $(0.17)...

BioCardia Announced The Primary Endpoint R...
05/01/2024 11:16:29

$biocardia-announces-results-from-open-label-roll-in-cohort-of-patients-having-chronic-myocardial-ischemia-with-refractory-angina-showed-avg-increase-in-exercise-tolerance-of-107-seconds-and-an-avg--of-82-reduction-in-angina-episodes-at-the-primary-six-month-follow-up-endpoint$

BioCardia Announces Results From Open Labe...
05/01/2024 11:15:51

BioCardia Completes Enrollment Of CardiAMP...
04/25/2024 13:01:43